Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses

Immunity

Volumn 5, Issue 5, 1996, Pages 407-415

  Xu, Yang ^b   Cheng, Genhong ^a,b   Baltimore, David ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; TRAF 3; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEVELOPMENT; FLOW CYTOMETRY; HYPOGLYCEMIA; IMMUNE RESPONSE; IMMUNOBLOTTING; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030292777     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80497-5     Document Type: Article

References (33)

1. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M., et al. (1993). The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300.
2. Baker, S.J., and Reddy, E.P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9.
3. Cheng, G., and Baltimore, D. (1996). TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-κB activation. Genes Dev. 10, 963-973.
4. Cheng, G., Cleary, A.M., Ye, Z.S., Hong, D.I., Lederman, S., and Baltimore, D. (1995). Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498.
5. Ellis, T.M., Simms, P.E., Slivnick, D.J., Jack, H.M., and Fisher, R.I. (1993). CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J. Immunol. 151, 2380-2389.
6. Gedrich, R.W., Gilfillan, M.C., Duckett, C.S., Van Dongen, J.L., and Thompson, C.B. (1996). CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271, 12852-12858.
7. Gordon, J. (1995). CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev. 9, 53-56.
8. Grewal, I.S., Xu, J., and Flavell, R.A. (1995). Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378, 617-620.
9. Hintzen, R.Q., Lens, S.M., Lammers, K., Kuiper, H., Beckmann, M.P., and van Lier, R.A. (1995). Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154, 2612-2623.
10. Hollenbaugh, D., Grosmaire, L.S., Kullas, C.D., Chalupny, N.J., Braesch-Andersen, S., Noelle, R.J., Stamenkovic, I., Ledbetter, J.A., and Aruffo, A. (1992). The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11, 4313-4321.
11. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
12. Hu, H.M., O'Rourke, K., Boguski, M.S., and Dixit, V.M. (1994). A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072.
13. Janeway, C.A., Jr., and Bottomly, K. (1994). Signals and signs for lymphocyte responses. Cell 76, 275-285.
14. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H. (1994). The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
15. Kehry, M.R., and Castle, B.E. (1994). Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation. Semin. Immunol. 6, 287-294.
16. Lee, S.Y., Park, C.G., and Choi, Y. (1996). T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183, 669-674.
17. Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
18. McDonald, P.P., Cassatella, M.A., Bald, A., Maggi, E., Romagnani, S., Gruss, H.J., and Pizzolo, G. (1995). CD30 ligation induces nuclear factor-κB activation in human T cell lines. Eur. J. Immunol. 25, 2870-2876.
19. Meyaard, L., Kuiper, H., Otto, S.A., Wolthers, K.C., van Lier, R.A., and Miedema, F. (1995). Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals. Eur. J. Immunol. 25, 232-237.
20. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
21. Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C.F., Yagita, H., and Okumura, K. (1996). TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271, 14661-14664.
22. Noelle, R.J. (1996). CD40 and its ligand in host defense. Immunity 4, 415-419.
23. Probert, L., Keffer, J., Corbella, P., Cazlaris, H., Patsavoudi, E., Stephens, S., Kaslaris, E., Kioussis, D., and Kollias, G. (1993). Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J. Immunol. 151, 1894-1906.
24. Regnier, C.H., Tomasetto, C., Moog-Lutz, C., Chenard, M.P., Wendling, C., Basset, P., and Rio, M.C. (1995). Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715-25721.
25. Rothe, M., Wong, S.C., Henzel, W.J., and Goeddel, D.V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
26. Rothe, M., Sarma, V., Dixit, V.M., and Goeddel, D.V. (1995). TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424-1427.
27. Sato, T., Irie, S., and Reed, J.C. (1995). A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358, 113-118.
28. Sha, W.C., Liou, H.C., Tuomanen, E.I., and Baltimore, D. (1995). Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330.
29. Smith, C.A., Farrah, T., and Goodwin, R.G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
30. Turner, M., Mee, P.J., Costello, P.S., Williams, O., Price, A.A., Duddy, L.P., Furlong, M.T., Geahlen, R.L. and Tybulewicz, V.L. (1995). Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase syk. Nature 378, 298-302.
31. van Essen, D., Kikutani, H., and Gray, D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623.
32. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T.J., Elsemore, J., Noelle, R.J., and Flavell, R.A. (1994). Mice deficient for the CD40 ligand. Immunity 1, 423-431.
33. Xu, Y., Davidson, L., Alt, F.W., and Baltimore, D. (1996). Deletion of the Igκ light chain intronic enhancer/matrix attachment region impairs but does not abolish VκJκ rearrangement. Immunity 4, 377-385.